WolverHeme Happy Hour

著者: Bernard Marini Anthony Perissinotti et al.
  • サマリー

  • Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
    Bernard Marini, Anthony Perissinotti, et al.
    続きを読む 一部表示

あらすじ・解説

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
Bernard Marini, Anthony Perissinotti, et al.
エピソード
  • CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined
    2025/05/05

    This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinical trials. Tycel Phillips, MD, and Manju Sengar, MD join Anthony and Bernie for a great discussion of the trials and how they should impact practice!


    Join the Common Sense Oncology movement here! https://commonsenseoncology.org/

    続きを読む 一部表示
    1 時間 11 分
  • Dex and the Cytokine City: Managing CRS with Bispecifics
    2025/04/07

    In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal management of CRS in patients receiving bispecific antibodies!


    Inspired by this recent paper:

    https://www.nature.com/articles/s41408-025-01222-y

    続きを読む 一部表示
    1 時間
  • LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML
    2025/03/11

    In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be using this agent in AML? Tune in to find out!

    続きを読む 一部表示
    1 時間 5 分

WolverHeme Happy Hourに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。